Keklikoglou et al. [140] showed that in a mouse model of pancreatic neuroendocrine tumor (PNET), de novo POSTN deposition adapted the tumor to chronic inhibition of VEGFA by sustaining macrophage infiltration. The gene discussed is POSTN; the disease is primitive neuroectodermal tumor.